An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy

Recruiting

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

Trial locations(1 site)

South Korea

Severance Hospital, Yonsei University Health System, Seoul, Seodaemun-gu